🇺🇸 Pfizer BNT162b2 COVID-19 vaccine in United States

Pfizer BNT162b2 COVID-19 vaccine (Pfizer BNT162b2 COVID-19 vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pfizer BNT162b2 COVID-19 vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pfizer BNT162b2 COVID-19 vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pfizer BNT162b2 COVID-19 vaccine in United States?

National Institute of Allergy and Infectious Diseases (NIAID) is the originator. The local marketing authorisation holder may differ — check the official source linked above.